Fig. 1: Outcomes of pediatric patients with mature non-Hodgkin lymphoma treated with CD19 CAR T cells.
From: CD28-costimulated CD19 CAR-T cells for pediatric mature non-Hodgkin B-cell lymphoma
a swimmers plot depicting response, further therapy, relapse and mortality. b Kaplan-Meier curve of overall survival (OS, black line) and event-free survival (EFS, dashed grey line).
